Lung Scintigraphy More Reliable Than CTA In Excluding Pulmonary Embolism In Pregnant Patients
Posted on: Tuesday, 20 October 2009, 18:18 CDT
A medical imaging procedure known as lung scintigraphy may be more reliable than pulmonary CT angiography (CTA) for identifying or excluding pulmonary embolism (PE) in pregnant patients, according to a study published in the November issue of the American Journal of Roentgenology.
PE, a blood clot lodged in an artery supplying the lungs, is the leading cause of maternal death in pregnancy. CTA is the imaging modality of choice for the diagnosis of PE, however lung scintigraphy, a form of radionuclide imaging that produces two-dimensional images, has shown to produce better diagnostic quality images more often than CTA in pregnant patients.
"Our study analyzed 28 CTA studies and 25 lung scintigraphy studies performed on a group of 50 patients," said Carole A. Ridge, M.D., lead author of the study. "The results showed that lung scintigraphy is more reliable than CTA for the diagnosis of PE. Only one out of 25 lung scintigraphic studies was inadequate for diagnosis; compared to ten out of 28 CTA examinations that were found to be inadequate for diagnosis," she said. Examinations were considered inadequate when poor image quality prohibited a diagnosis.
"During CTA in pregnant patients, it is hard to achieve optimal image quality because of the hemodynamic effects (changes in blood flow and circulation) of pregnancy," said Dr. Ridge.
"Our findings confirm what recent reports in the literature have suggested — CTA is less reliable for the diagnosis of PE in pregnant patients. Lung scintigraphy is more reliable than CTA for the diagnosis or exclusion of PE in pregnant patients, and should be considered the imaging technique of choice unless the CTA image technique can be optimized for the pregnant patient," she said.
---
On the Net:
Related Articles
- Combination Of PET/CT Tests Expedite Diagnosis Of Lung Cancer
- St. Jude Medical Announces First Patient Implants in Clinical Study Evaluating Deep Brain Stimulation for Depression
- Cogentus Enrolls First European Patient in Phase III Study of Combination Drug
- ACHIEVE Imaging Study Discontinued
- Fralex Reaches 100th Patient Milestone in Fibromyalgia Study
- Columbia Laboratories Receives IRB Approval to Begin Enrolling Patients in Phase III Study of PROCHIEVE(R) 8% (Progesterone Gel) to Reduce Risk of Preterm Birth in Short Cervix Population
- Epigenomics AG Demonstrates Feasibility of Convenient Blood Test for Lung Cancer Detection in Clinical Study
- The Diagnosis of Lung Cancer
- Inoveon of OKC Completes 40,000th iScan Retinal Imaging Study
- Disturbed Right Ventricular Diastolic Function in Patients With Systemic Sclerosis*: A Doppler Tissue Imaging Study
 |
 |
User Comments (0)
RSS Feeds